We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Routine Screening Prevents Majority of Cervical Cancers

By HospiMedica International staff writers
Posted on 19 Feb 2020
Print article
A new study suggests that screening for human papillomaviruses (HPV) every three years instead of annually is sufficient to prevent most cervical cancers.

Researchers at the University of New Mexico (UNM; Albuquerque, USA), Queen Mary, University of London (QMUL; United Kingdom), and other institutions conducted a case-control study using records from population-based registries in New Mexico (USA). The cases selected were women diagnosed with cervical cancer between 2006 and 2016, with five controls per case matched by age and place of residence. The results of all cervical screening and diagnostic tests since 2006 were identified from the New Mexico HPV Pap Registry.

The researchers then estimated the odds ratio of nonlocalized (Stage II+) and localized (Stage I) cervical cancer associated with attending screening in the three years prior to case-diagnosis, as compared to women who were not screened in five years. The results showed that only 38% of cases and 61% of the controls attended screening during a three-year period. Women screened in the three years prior to diagnosis had 83% lower risk of nonlocalized cancer and 48% lower odds of localized cancer, compared to women not screened in the five years prior to diagnosis.

Women who received a negative screening test were very unlikely to be diagnosed with cervical cancer in the following three and-a-half to five years, as compared to women with no negative screens in the five years prior to cervical cancer diagnosis. The researchers thus concluded that routine, three-yearly screening is effective at preventing both localized and nonlocalized cervical cancers, with no additional benefit of more frequent screening. The study was published on December 13, 2019, in the International Journal of Cancer.

“Screening is super important for catching cancers before they have spread, and the value of a negative screen is huge. If you screen, we can show that screening prevents more than 80% of distant cancer and about 50% of local cancer. And the local cancer is easily treatable,” said senior author Professor Cosette Wheeler, PhD, of UNM. “This study gives real-world evidence to assure New Mexican women and their health care providers that screening for cervical cancer every three years safely finds cancer early, and that screening more frequently has no additional benefit.”

DNA testing for HPV has gained widespread acceptance as an additional cervical cancer screening tool and as follow-up to abnormal changes detected with a Pap smear. There are now several such DNA HPV tests that can detect either the majority of the high-risk types of HPV or specific subtypes, such as HPV-16 and HPV-18. Screening women younger than age 30 is generally not recommended, since infections with HPV are relatively common in this age group, often resolving without treatment or complications.

Related Links:
University of New Mexico
Queen Mary, University of London


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Electrosurgical Unit
es 120

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.